Monday 9 April 2018

United States Breast Cancer Screening Market is expected to reach more than US$ 5.8 Billion by 2022

Report Sellers has added a new market research report “United States Breast Cancer Screening Market Analysis to its offerings. The report is an in-depth market study providing accurate market insights including the latest trends, forecast, competitive insights, etc.
Long-term Growth Projection:
  • Mammography grasp the dominant share in the United States Breast Cancer Screening Market
  • Breast MRI Screening market is likely to reach more than US$ 350 Million by 2022
  • Number of mammography screening population in United States will increase to more than 50 Million by 2022
Market growth can be attributed to factors such as increasing incidence of breast cancer, increasing awareness related to early breast cancer detection, growing government investments and funding for breast cancer screening, technological advancement in breast imaging technologies and implementation of several initiatives to create awareness about the early detection of breast cancer.
“United States Breast Cancer Screening Market Analysis: By Type, Share, Cases, Clinical Trials Insight, Reimbursement, Competitive Strategies and Forecast, 2017 – 2022” provides a deep and thorough evaluation of the United States Breast Cancer Screening Market. The report provides an in-depth analysis of the breast cancer invasive, in situ and men cases and added breast cancer death figures of both men and women in United States. Furthermore, the report also covered mammography screening population from 2010 to 2022.

Market outlook in value terms has been analyzed based on historical, current and potential trends and the market is projected from 2017 to 2022. The breast cancer screening market is segmented based on its product types: Mammography, Breast MRI, and Breast Ultrasound. Additionally, the report includes assessment of clinical trials and reimbursement pattern. The report also explores detailed description of growth drivers and inhibitors of the United States Breast Cancer Screening Market.
The report concludes with the profiles of major manufacturers of Mammography, MRI, and Ultrasound such as Hologic, Hitachi Medical Corporation, Siemens Healthineers, Philips Healthcare, Toshiba Medical Systems Corporation and GE Healthcare. The major manufacturers are evaluated on various parameters such as business overview, marketed products and latest development and trends

Browse through the complete description and in-depth TOC on United States Breast Cancer Screening Market

https://www.reportsellers.com/market-research-report/breast-cancer-screening-market
Major Companies Covered in This Report
  • Hitachi Medical Corporation
  • Siemen Healthineers
  • Philips Healthcare
  • Toshiba Medical Systems Corporation
  • GE Healthcare
  • Hologic
Request Sample herehttps://www.reportsellers.com/market-research-report/breast-cancer-screening-market

Related Reports
https://www.reportsellers.com/market-research-report/Hepatitis-Viruses-Rapid-Tests–POC-Point-Of-Care–
https://www.reportsellers.com/market-research-report/Dyspareunia-Global-Clinical-Trials-Review-H2-2017
https://www.reportsellers.com/market-research-report/Dysmenorrhea-Global-Clinical-Trials-Review-H2-2017

We have a large number of reports in other Diagnostics Industry which can be accessed in the following link:
https://www.reportsellers.com/sub-category/Diagnostics-market-research-report

About Report Sellers
Report Sellers is a premium market research service provider offering market reports in varied sectors. We have a team of experienced analysts and publishers who continuously track the latest trends in different industries.

Report Sellers is a brand of global repute and offers the best-suited research services to its clients globally in the most satisfying manner. We have a strong network of industry experts who have successfully delivered complex research assignments in niche and top markets.

For more information, contact
Aditya Joshi
Report Sellers
Email: sales@reportsellers.com
Direct: +1-214-396-2385

No comments:

Post a Comment